Srs Capital Advisors, Inc. Regenxbio Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.95 Billion
- Q2 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 46 shares of RGNX stock, worth $483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46
Previous 46
-0.0%
Holding current value
$483
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGNX
# of Institutions
181Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$90.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$50.2 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$45.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$36 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$19.4 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $454M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...